Based on the one-year price targets offered by 7 analysts, the average target price for Oxford BioMedica PLC (LSE:OXB) is $8.75 with a high estimate of $11.70 and a low estimate of $7.72. The average ...
Oxford, UK – OXB (LSE: OXB), a global quality and innovation-led cell and gene therapy CDMO, has been honoured with a spot on the Financial Times’ prestigious ‘UK Best Employers 2025’ list. This ...
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results